nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Dactinomycin—muscle cancer	0.204	0.258	CbGbCtD
Lomitapide—ABCB1—Vincristine—muscle cancer	0.126	0.159	CbGbCtD
Lomitapide—ABCB1—Etoposide—muscle cancer	0.115	0.146	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—muscle cancer	0.0785	0.0993	CbGbCtD
Lomitapide—ABCB1—Methotrexate—muscle cancer	0.076	0.0962	CbGbCtD
Lomitapide—CYP3A4—Vincristine—muscle cancer	0.0752	0.0952	CbGbCtD
Lomitapide—CYP3A4—Etoposide—muscle cancer	0.0689	0.0873	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—muscle cancer	0.047	0.0595	CbGbCtD
Lomitapide—Antrafenine—PTGS2—muscle cancer	0.00939	1	CrCbGaD
Lomitapide—Hepatomegaly—Dactinomycin—muscle cancer	0.00438	0.0218	CcSEcCtD
Lomitapide—Anorectal discomfort—Etoposide—muscle cancer	0.0041	0.0205	CcSEcCtD
Lomitapide—Reaction gastrointestinal—Methotrexate—muscle cancer	0.00402	0.0201	CcSEcCtD
Lomitapide—Hepatotoxicity—Dactinomycin—muscle cancer	0.00401	0.02	CcSEcCtD
Lomitapide—Rectal tenesmus—Doxorubicin—muscle cancer	0.00312	0.0156	CcSEcCtD
Lomitapide—Drug interaction—Vincristine—muscle cancer	0.00298	0.0149	CcSEcCtD
Lomitapide—Hepatotoxicity—Etoposide—muscle cancer	0.0029	0.0145	CcSEcCtD
Lomitapide—Gait disturbance—Vincristine—muscle cancer	0.00283	0.0141	CcSEcCtD
Lomitapide—Prothrombin level increased—Doxorubicin—muscle cancer	0.00283	0.0141	CcSEcCtD
Lomitapide—Proctalgia—Doxorubicin—muscle cancer	0.00248	0.0124	CcSEcCtD
Lomitapide—Anorectal discomfort—Doxorubicin—muscle cancer	0.00213	0.0106	CcSEcCtD
Lomitapide—Liver function test abnormal—Dactinomycin—muscle cancer	0.00208	0.0104	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.00202	0.0101	CcSEcCtD
Lomitapide—Pain in extremity—Vincristine—muscle cancer	0.00201	0.01	CcSEcCtD
Lomitapide—Haematemesis—Methotrexate—muscle cancer	0.00193	0.00964	CcSEcCtD
Lomitapide—Transaminases increased—Doxorubicin—muscle cancer	0.00191	0.00953	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.00187	0.00933	CcSEcCtD
Lomitapide—Dehydration—Vincristine—muscle cancer	0.00187	0.00932	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00181	0.00902	CcSEcCtD
Lomitapide—Hepatotoxicity—Methotrexate—muscle cancer	0.00174	0.00867	CcSEcCtD
Lomitapide—Haematemesis—Doxorubicin—muscle cancer	0.00167	0.00835	CcSEcCtD
Lomitapide—Hepatomegaly—Doxorubicin—muscle cancer	0.00164	0.00819	CcSEcCtD
Lomitapide—Blister—Doxorubicin—muscle cancer	0.00161	0.00805	CcSEcCtD
Lomitapide—Weight decreased—Vincristine—muscle cancer	0.00157	0.00784	CcSEcCtD
Lomitapide—Rash erythematous—Doxorubicin—muscle cancer	0.00152	0.00757	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00143	0.00716	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00142	0.00708	CcSEcCtD
Lomitapide—Chills—Dactinomycin—muscle cancer	0.0014	0.00696	CcSEcCtD
Lomitapide—Urinary tract disorder—Vincristine—muscle cancer	0.00137	0.00685	CcSEcCtD
Lomitapide—Connective tissue disorder—Vincristine—muscle cancer	0.00137	0.00681	CcSEcCtD
Lomitapide—Urethral disorder—Vincristine—muscle cancer	0.00136	0.00679	CcSEcCtD
Lomitapide—Cardiac disorder—Vincristine—muscle cancer	0.00129	0.00643	CcSEcCtD
Lomitapide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00126	0.00627	CcSEcCtD
Lomitapide—Infestation—Etoposide—muscle cancer	0.00125	0.00626	CcSEcCtD
Lomitapide—Infestation NOS—Etoposide—muscle cancer	0.00125	0.00626	CcSEcCtD
Lomitapide—Mediastinal disorder—Vincristine—muscle cancer	0.00125	0.00625	CcSEcCtD
Lomitapide—Anaemia—Dactinomycin—muscle cancer	0.00125	0.00624	CcSEcCtD
Lomitapide—Blood bilirubin increased—Doxorubicin—muscle cancer	0.00123	0.00613	CcSEcCtD
Lomitapide—Malaise—Dactinomycin—muscle cancer	0.00122	0.00609	CcSEcCtD
Lomitapide—Ecchymosis—Methotrexate—muscle cancer	0.00121	0.00606	CcSEcCtD
Lomitapide—Gait disturbance—Doxorubicin—muscle cancer	0.00119	0.00594	CcSEcCtD
Lomitapide—Hepatobiliary disease—Etoposide—muscle cancer	0.00119	0.00592	CcSEcCtD
Lomitapide—Back pain—Vincristine—muscle cancer	0.00117	0.00584	CcSEcCtD
Lomitapide—Myalgia—Dactinomycin—muscle cancer	0.00115	0.00575	CcSEcCtD
Lomitapide—Eructation—Doxorubicin—muscle cancer	0.00114	0.0057	CcSEcCtD
Lomitapide—Discomfort—Dactinomycin—muscle cancer	0.00114	0.00568	CcSEcCtD
Lomitapide—Anaemia—Vincristine—muscle cancer	0.00112	0.00558	CcSEcCtD
Lomitapide—Urinary tract disorder—Etoposide—muscle cancer	0.00111	0.00555	CcSEcCtD
Lomitapide—Urethral disorder—Etoposide—muscle cancer	0.0011	0.0055	CcSEcCtD
Lomitapide—Infection—Dactinomycin—muscle cancer	0.0011	0.00548	CcSEcCtD
Lomitapide—Vertigo—Vincristine—muscle cancer	0.00109	0.00542	CcSEcCtD
Lomitapide—Eye disorder—Etoposide—muscle cancer	0.00105	0.00525	CcSEcCtD
Lomitapide—Ecchymosis—Doxorubicin—muscle cancer	0.00105	0.00524	CcSEcCtD
Lomitapide—Cardiac disorder—Etoposide—muscle cancer	0.00104	0.00521	CcSEcCtD
Lomitapide—Myalgia—Vincristine—muscle cancer	0.00103	0.00514	CcSEcCtD
Lomitapide—Mediastinal disorder—Etoposide—muscle cancer	0.00101	0.00506	CcSEcCtD
Lomitapide—Chills—Etoposide—muscle cancer	0.00101	0.00504	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00101	0.00502	CcSEcCtD
Lomitapide—Infection—Vincristine—muscle cancer	0.000981	0.00489	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00097	0.00484	CcSEcCtD
Lomitapide—Nervous system disorder—Vincristine—muscle cancer	0.000968	0.00483	CcSEcCtD
Lomitapide—Decreased appetite—Dactinomycin—muscle cancer	0.00096	0.00479	CcSEcCtD
Lomitapide—Hyperhidrosis—Vincristine—muscle cancer	0.000954	0.00476	CcSEcCtD
Lomitapide—Fatigue—Dactinomycin—muscle cancer	0.000953	0.00475	CcSEcCtD
Lomitapide—Back pain—Etoposide—muscle cancer	0.000948	0.00473	CcSEcCtD
Lomitapide—Muscle spasms—Etoposide—muscle cancer	0.000942	0.0047	CcSEcCtD
Lomitapide—Feeling abnormal—Dactinomycin—muscle cancer	0.00091	0.00454	CcSEcCtD
Lomitapide—Ill-defined disorder—Etoposide—muscle cancer	0.000909	0.00454	CcSEcCtD
Lomitapide—Anaemia—Etoposide—muscle cancer	0.000906	0.00452	CcSEcCtD
Lomitapide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000903	0.00451	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—muscle cancer	0.0009	0.00449	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000899	0.00449	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—muscle cancer	0.000898	0.00448	CcSEcCtD
Lomitapide—Paraesthesia—Vincristine—muscle cancer	0.000886	0.00442	CcSEcCtD
Lomitapide—Malaise—Etoposide—muscle cancer	0.000884	0.00441	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—muscle cancer	0.000883	0.0044	CcSEcCtD
Lomitapide—Vertigo—Etoposide—muscle cancer	0.00088	0.00439	CcSEcCtD
Lomitapide—Abdominal pain—Dactinomycin—muscle cancer	0.000873	0.00436	CcSEcCtD
Lomitapide—Body temperature increased—Dactinomycin—muscle cancer	0.000873	0.00436	CcSEcCtD
Lomitapide—Decreased appetite—Vincristine—muscle cancer	0.000858	0.00428	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Vincristine—muscle cancer	0.000852	0.00425	CcSEcCtD
Lomitapide—Fatigue—Vincristine—muscle cancer	0.000851	0.00425	CcSEcCtD
Lomitapide—Constipation—Vincristine—muscle cancer	0.000844	0.00421	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—muscle cancer	0.000844	0.00421	CcSEcCtD
Lomitapide—Chest pain—Etoposide—muscle cancer	0.000834	0.00416	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—muscle cancer	0.000831	0.00414	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000828	0.00413	CcSEcCtD
Lomitapide—Discomfort—Etoposide—muscle cancer	0.000824	0.00411	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—muscle cancer	0.000807	0.00403	CcSEcCtD
Lomitapide—Gastrointestinal pain—Vincristine—muscle cancer	0.000807	0.00403	CcSEcCtD
Lomitapide—Infection—Etoposide—muscle cancer	0.000794	0.00396	CcSEcCtD
Lomitapide—Asthenia—Dactinomycin—muscle cancer	0.000793	0.00395	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—muscle cancer	0.000785	0.00392	CcSEcCtD
Lomitapide—Abdominal pain—Vincristine—muscle cancer	0.00078	0.00389	CcSEcCtD
Lomitapide—Body temperature increased—Vincristine—muscle cancer	0.00078	0.00389	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—muscle cancer	0.000779	0.00389	CcSEcCtD
Lomitapide—Skin disorder—Etoposide—muscle cancer	0.000777	0.00388	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—muscle cancer	0.000773	0.00386	CcSEcCtD
Lomitapide—Hyperhidrosis—Etoposide—muscle cancer	0.000773	0.00386	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—muscle cancer	0.000771	0.00385	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00076	0.00379	CcSEcCtD
Lomitapide—Diarrhoea—Dactinomycin—muscle cancer	0.000756	0.00377	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—muscle cancer	0.000755	0.00376	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—muscle cancer	0.000751	0.00375	CcSEcCtD
Lomitapide—Infestation—Methotrexate—muscle cancer	0.000751	0.00375	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—muscle cancer	0.000747	0.00373	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000744	0.00371	CcSEcCtD
Lomitapide—Abdominal distension—Doxorubicin—muscle cancer	0.000734	0.00366	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—muscle cancer	0.000729	0.00364	CcSEcCtD
Lomitapide—Paraesthesia—Etoposide—muscle cancer	0.000718	0.00358	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—muscle cancer	0.000716	0.00357	CcSEcCtD
Lomitapide—Somnolence—Etoposide—muscle cancer	0.000711	0.00355	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—muscle cancer	0.00071	0.00354	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—muscle cancer	0.00071	0.00354	CcSEcCtD
Lomitapide—Asthenia—Vincristine—muscle cancer	0.000708	0.00353	CcSEcCtD
Lomitapide—Vomiting—Dactinomycin—muscle cancer	0.000702	0.0035	CcSEcCtD
Lomitapide—Decreased appetite—Etoposide—muscle cancer	0.000695	0.00347	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00069	0.00344	CcSEcCtD
Lomitapide—Fatigue—Etoposide—muscle cancer	0.000689	0.00344	CcSEcCtD
Lomitapide—Constipation—Etoposide—muscle cancer	0.000684	0.00341	CcSEcCtD
Lomitapide—Diarrhoea—Vincristine—muscle cancer	0.000675	0.00337	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—muscle cancer	0.000666	0.00332	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—muscle cancer	0.000661	0.0033	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—muscle cancer	0.00066	0.00329	CcSEcCtD
Lomitapide—Feeling abnormal—Etoposide—muscle cancer	0.000659	0.00329	CcSEcCtD
Lomitapide—Nausea—Dactinomycin—muscle cancer	0.000656	0.00327	CcSEcCtD
Lomitapide—Gastrointestinal pain—Etoposide—muscle cancer	0.000654	0.00326	CcSEcCtD
Lomitapide—Dizziness—Vincristine—muscle cancer	0.000653	0.00326	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—muscle cancer	0.00065	0.00324	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—muscle cancer	0.00065	0.00324	CcSEcCtD
Lomitapide—Abdominal pain—Etoposide—muscle cancer	0.000632	0.00315	CcSEcCtD
Lomitapide—Body temperature increased—Etoposide—muscle cancer	0.000632	0.00315	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—muscle cancer	0.00063	0.00314	CcSEcCtD
Lomitapide—Vomiting—Vincristine—muscle cancer	0.000628	0.00313	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—muscle cancer	0.000626	0.00312	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—muscle cancer	0.00062	0.00309	CcSEcCtD
Lomitapide—Headache—Vincristine—muscle cancer	0.000618	0.00309	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000615	0.00307	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—muscle cancer	0.00061	0.00304	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—muscle cancer	0.000608	0.00303	CcSEcCtD
Lomitapide—Chills—Methotrexate—muscle cancer	0.000605	0.00302	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—muscle cancer	0.000587	0.00293	CcSEcCtD
Lomitapide—Nausea—Vincristine—muscle cancer	0.000586	0.00293	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—muscle cancer	0.000577	0.00288	CcSEcCtD
Lomitapide—Asthenia—Etoposide—muscle cancer	0.000574	0.00286	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—muscle cancer	0.000574	0.00286	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—muscle cancer	0.000572	0.00285	CcSEcCtD
Lomitapide—Back pain—Methotrexate—muscle cancer	0.000568	0.00283	CcSEcCtD
Lomitapide—Diarrhoea—Etoposide—muscle cancer	0.000547	0.00273	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—muscle cancer	0.000546	0.00272	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—muscle cancer	0.000545	0.00272	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—muscle cancer	0.000542	0.00271	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—muscle cancer	0.000542	0.0027	CcSEcCtD
Lomitapide—Malaise—Methotrexate—muscle cancer	0.000529	0.00264	CcSEcCtD
Lomitapide—Dizziness—Etoposide—muscle cancer	0.000529	0.00264	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—muscle cancer	0.000527	0.00263	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—muscle cancer	0.000526	0.00262	CcSEcCtD
Lomitapide—Chills—Doxorubicin—muscle cancer	0.000524	0.00261	CcSEcCtD
Lomitapide—Vomiting—Etoposide—muscle cancer	0.000508	0.00254	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—muscle cancer	0.000508	0.00254	CcSEcCtD
Lomitapide—Headache—Etoposide—muscle cancer	0.000501	0.0025	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—muscle cancer	0.000501	0.0025	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—muscle cancer	0.0005	0.00249	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—muscle cancer	0.0005	0.00249	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—muscle cancer	0.0005	0.00249	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000496	0.00248	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—muscle cancer	0.000494	0.00246	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—muscle cancer	0.000492	0.00245	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—muscle cancer	0.000489	0.00244	CcSEcCtD
Lomitapide—Infection—Methotrexate—muscle cancer	0.000476	0.00237	CcSEcCtD
Lomitapide—Nausea—Etoposide—muscle cancer	0.000475	0.00237	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—muscle cancer	0.000472	0.00235	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—muscle cancer	0.00047	0.00234	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—muscle cancer	0.00047	0.00234	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—muscle cancer	0.000465	0.00232	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—muscle cancer	0.000463	0.00231	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—muscle cancer	0.000458	0.00229	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—muscle cancer	0.000457	0.00228	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—muscle cancer	0.000449	0.00224	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000436	0.00218	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—muscle cancer	0.000433	0.00216	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—muscle cancer	0.000433	0.00216	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—muscle cancer	0.000433	0.00216	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—muscle cancer	0.00043	0.00215	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00043	0.00214	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—muscle cancer	0.000427	0.00213	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—muscle cancer	0.000426	0.00212	CcSEcCtD
Lomitapide—Dry mouth—Doxorubicin—muscle cancer	0.000423	0.00211	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—muscle cancer	0.000422	0.0021	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—muscle cancer	0.000416	0.00208	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000414	0.00206	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—muscle cancer	0.000413	0.00206	CcSEcCtD
Lomitapide—Infection—Doxorubicin—muscle cancer	0.000412	0.00206	CcSEcCtD
Lomitapide—Nervous system disorder—Doxorubicin—muscle cancer	0.000407	0.00203	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—muscle cancer	0.000403	0.00201	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000401	0.002	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—muscle cancer	0.000395	0.00197	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—muscle cancer	0.000392	0.00195	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—muscle cancer	0.000379	0.00189	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—muscle cancer	0.000379	0.00189	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000378	0.00189	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—muscle cancer	0.000372	0.00186	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—muscle cancer	0.000369	0.00184	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—muscle cancer	0.000365	0.00182	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—muscle cancer	0.000361	0.0018	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000358	0.00179	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—muscle cancer	0.000358	0.00178	CcSEcCtD
Lomitapide—Constipation—Doxorubicin—muscle cancer	0.000355	0.00177	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—muscle cancer	0.000344	0.00171	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—muscle cancer	0.000342	0.00171	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000339	0.00169	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—muscle cancer	0.000328	0.00164	CcSEcCtD
Lomitapide—Abdominal pain—Doxorubicin—muscle cancer	0.000328	0.00164	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—muscle cancer	0.000328	0.00163	CcSEcCtD
Lomitapide—Dizziness—Methotrexate—muscle cancer	0.000317	0.00158	CcSEcCtD
Lomitapide—Vomiting—Methotrexate—muscle cancer	0.000305	0.00152	CcSEcCtD
Lomitapide—Headache—Methotrexate—muscle cancer	0.0003	0.0015	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—muscle cancer	0.000298	0.00148	CcSEcCtD
Lomitapide—Nausea—Methotrexate—muscle cancer	0.000285	0.00142	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—muscle cancer	0.000284	0.00142	CcSEcCtD
Lomitapide—Dizziness—Doxorubicin—muscle cancer	0.000274	0.00137	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—muscle cancer	0.000264	0.00132	CcSEcCtD
Lomitapide—Headache—Doxorubicin—muscle cancer	0.00026	0.0013	CcSEcCtD
Lomitapide—Nausea—Doxorubicin—muscle cancer	0.000246	0.00123	CcSEcCtD
